Viehbacher?s First Day On The Job At Sanofi Pharmalot, NJ - Sanofi had pressed ahead with tests on thousands of patients, hoping to win approval as a diabetes treatment, even after an FDA panel last year rejected the ...
Stock Picks for Healthy Returns Motley Fool - Nov 25, 2008 ... and Eli Lilly (LLY) ? with LLY still waiting on a FDA decision for Effient (prasugrel) to compete with multi-billion dollar blood thinner Plavix. ...
Germany: UPDATE: The German Plavix Case: Loopholes In European ... Mondaq News Alerts (registration), UK - Nov 12, 2008 In a strict sense, clopidogrel besylate as the API of Clopidogrel YES so far has not been in medicinal use at all in the European Community. ...
A Backlog Of Decisions Is Building At The FDA istockAnalyst.com (press release), OR - Nov 7, 2008 Promacta was endorsed by an FDA panel for short-term use this past summer and Amgen (AMGN) received FDA approval in late August for Npate as the first ...
Is Lilly's prasugrel safe? FiercePharma, DC - Nov 12, 2008 ... been awaiting FDA approval since it submitted the highly-anticipated medication for review last December. Prasugrel is a direct competitor of Plavix, ...LLY
Pharmaceuticals Industry Zacks.com, IL - Nov 21, 2008 (BMY) blood-thinner Plavix or Pfizer's anti-cholesterol agent Lipitor because of the credit crunch is the epitome of irrational anxiety. ...PFE - LLY
Source: Google News
Recent News and Articles on the Keywords: plavix + fda + 78,700 Related to the article below (Last Update: 8/7/2008)
Global Generics Rush: Plavix in Germany, Depakote in US Wall Street Journal Blogs, NY - Jul 30, 2008 Abbott?s Depakote, approved for epilepsy, bipolar disorder and migraines, is now generic in the US, the FDA said. A bunch of generics manufacturers ...
Pharma alliances, a shot in the arm Sify, India - Jul 12, 2008 At the same time, lacking are new blockbusters to replace ones such as Lipitor, Plavix and Zyprexa. Eli Lilly?s anti-blood-clotting drug Prasugrel posted ...OTC:RBXLY - PINK:DSKYF - TYO:4568
Ask Dr. H: A puzzling aspect of age and a swelling prostate Philadelphia Inquirer, PA - Jul 21, 2008 After the procedure, my doctor placed me on Plavix and aspirin, which I'm still taking. He used coated stents that are supposed to cut my chances of getting ...
Sanofi-aventis News PharmaLive.com (press release), PA - Jul 31, 2008 In the United States, sales of Plavix(R) (consolidated by Bristol Myers Squibb - BMS) totaled $1208 million in the second quarter of 2008, compared with ...SNY
Bristol-Myers, Eli Lilly post strong 2Q results The Associated Press - Jul 24, 2008 Plavix posted a 17 percent jump in sales in the quarter, to $1.39 billion, or nearly one-third of Bristol-Myers's total pharmaceutical sales of $4.5 billion ...LLY - BMY
Clopidogrel-Associated TTP A Zakarija, N Bandarenko, DK Pandey, A Auerbach, … - Stroke, 2004 - Am Heart Assoc ... in a new window], TABLE 1. Completeness and Timeliness of Cases Reported by Independent
Researchers, Pharmaceutical Suppliers of Clopidogrel, and the FDA. ...
Platelet ADP receptor antagonists: ticlopidine and clopidogrel - AK Jacobson - Best Practice & Research Clinical Haematology, 2004 - Elsevier ... Clopidogrel has since been approved by the FDA for reduction of thrombotic events
in recent myocardial infarction, stroke or established peripheral arterial ...
Delaying Generic Competition--Corporate Payoffs and the Future of Plavix - M Shuchman - New England Journal of Medicine, 2006 - content.nejm.org ... According to Apotex court filings, in early 2006, when the company learned that
the FDA would soon approve its generic clopidogrel, it began to produce a large ...
Clopidogrel versus Aspirin and Esomeprazole to Prevent Recurrent Ulcer Bleeding - FKL Chan, JYL Ching, LCT Hung, VWS Wong, VKS Leung … - New England Journal of Medicine, 2005 - content.nejm.org ... Approval package for application number 20-839/SE1-019 (Plavix). (Accessed December
27, 2004, at http://www.fda.gov/cder/foi/nda/index97.htm); Fork FT, Lafolie ...
[CITATION]FDA Approves New Medical Use for Plavix-Drug benefits Patients with common form of Heart Attack US Food, D Administration - 2006 - Accessed
[PDF]Clopidogrel now available to treat ACS - FDA Serono - nursing2006.com ... The FDA has approved Plavix (clopidogrel) to treat acute coronary syndrome
(ACS) without ST- segment elevation, a new indication. ... -
Source: Google Scholar
FDA approves expanded use for Plavix
The popular blood-thinning drug Plavix received expanded federal approval Thursday to prevent the sudden blockage of arteries that can lead to heart attack, stroke and death.
The approval means Plavix may be used to treat patients who have had a type of severe heart attack called acute ST-segment elevation myocardial infarction, or STEMI, and who are not going to have angioplasty to clear blocked arteries, the Food and Drug Administration said.
The sudden, total blockage of an artery can provoke the type of heart attack. An estimated 500,000 Americans suffer such heart attacks each year, according to the American Heart Association.
In 1997, Plavix, now the world's second best-selling drug, received FDA approval to thin the blood and prevent clots that can block arteries.
The expanded approval comes as Bristol-Myers Squibb Co. and Sanofi-Aventis SA seek a court injunction to block Canadian drug company Apotex Corp. from selling a less expensive, generic version of Plavix. Sales of the drug last year were about $5.9 billion. A court hearing on the motion is set for Friday.
Serious side effects of Plavix, also known as clopidogrel bisulfate, include bleeding and, rarely, low white blood cell counts and low platelet counts with spontaneous bleeding and clotting, the FDA said.
